+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Hair Diseases Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hair Diseases Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Severe Acne Vulgaris Pipeline Analysis Report 2025 - Product Thumbnail Image

Severe Acne Vulgaris Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Moderate Psoriasis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Moderate Psoriasis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Dementia with Diabetes Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Dementia with Diabetes Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Acne Vulgaris Pipeline Analysis Report 2025 - Product Thumbnail Image

Acne Vulgaris Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Herpes Labialis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Labialis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Hunter Syndrome Pipeline Analysis Report 2025 - Product Thumbnail Image

Hunter Syndrome Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
Somatotropin Deficiency Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Somatotropin Deficiency Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Onychomycosis Pipeline Analysis Report 2025 - Product Thumbnail Image

Onychomycosis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Nasal Polyposis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Nasal Polyposis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Narcolepsy Pipeline Analysis Report 2025 - Product Thumbnail Image

Narcolepsy Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
GLP-1 Agonists Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

GLP-1 Agonists Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Cystinuria Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Cystinuria Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Ventricular Fibrillation Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Ventricular Fibrillation Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Mild Dry Eye Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Mild Dry Eye Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Seasonal Allergic Rhinitis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Seasonal Allergic Rhinitis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Palmar Hyperhidrosis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Palmar Hyperhidrosis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Opioid-induced Constipation Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Opioid-induced Constipation Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more